Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 53

1.

Two biomarker-directed randomized trials in European and Chinese patients with non-small-cell lung cancer: The BRCA1-RAP80 Expression Customization (BREC) studies.

Moran T, Wei J, Cobo M, Qian X, Domine M, Zou Z, Bover I, Wang L, Provencio M, Yu L, Chaib I, You C, Massuti B, Song Y, Vergnenegre A, Lu H, Lopez-Vivanco G, Hu W, Robinet G, Yan J, Insa A, Xu X, Majem M, Chen X, de Las Peñas R, Karachaliou N, Sala MA, Wu Q, Isla D, Zhou Y, Baize N, Zhang F, Garde J, Germonpre P, Rauh S, ALHusaini H, Sanchez-Ronco M, Drozdowskyj A, Sanchez JJ, Camps C, Liu B, Rosell R; on behalf of the Spanish Lung Cancer Group, the French Lung Cancer Group, the Comprehensive Cancer Centre of Drum Tower Hospital in Nanjing.

Ann Oncol. 2014 Aug 27. pii: mdu389. [Epub ahead of print]

PMID:
25164908
[PubMed - as supplied by publisher]
2.

A New Biomarker Panel in Bronchoalveolar Lavage for an Improved Lung Cancer Diagnosis.

Uribarri M, Hormaeche I, Zalacain R, Lopez-Vivanco G, Martinez A, Nagore D, Ruiz-Argüello MB.

J Thorac Oncol. 2014 Aug 7. [Epub ahead of print]

PMID:
25105437
[PubMed - as supplied by publisher]
3.

Adjuvant therapy with bemiparin in patients with limited-stage small cell lung cancer: results from the ABEL study.

Lecumberri R, López Vivanco G, Font A, González Billalabeitia E, Gúrpide A, Gómez Codina J, Isla D, Galán A, Bover I, Domine M, Vicente V, Rosell R, Rocha E.

Thromb Res. 2013;132(6):666-70. doi: 10.1016/j.thromres.2013.09.026. Epub 2013 Sep 27.

PMID:
24491267
[PubMed - indexed for MEDLINE]
4.

Preference for subcutaneous or intravenous administration of trastuzumab in patients with HER2-positive early breast cancer (PrefHer): an open-label randomised study.

Pivot X, Gligorov J, Müller V, Barrett-Lee P, Verma S, Knoop A, Curigliano G, Semiglazov V, López-Vivanco G, Jenkins V, Scotto N, Osborne S, Fallowfield L; PrefHer Study Group.

Lancet Oncol. 2013 Sep;14(10):962-70. doi: 10.1016/S1470-2045(13)70383-8. Epub 2013 Aug 19.

PMID:
23965225
[PubMed - indexed for MEDLINE]
5.

Thymidylate synthase expression determines pemetrexed targets and resistance development in tumour cells.

Buqué A, Aresti U, Calvo B, Sh Muhialdin J, Muñoz A, Carrera S, Azkona E, Rubio I, López-Vivanco G.

PLoS One. 2013 May 13;8(5):e63338. doi: 10.1371/journal.pone.0063338. Print 2013.

PMID:
23675481
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: a randomised phase II study.

Roy A, Cunningham D, Hawkins R, Sörbye H, Adenis A, Barcelo JR, Lopez-Vivanco G, Adler G, Canon JL, Lofts F, Castanon C, Fonseca E, Rixe O, Aparicio J, Cassinello J, Nicolson M, Mousseau M, Schalhorn A, D'Hondt L, Kerger J, Hossfeld DK, Garcia Giron C, Rodriguez R, Schoffski P, Misset JL.

Br J Cancer. 2012 Jul 24;107(3):435-41. doi: 10.1038/bjc.2012.286. Epub 2012 Jul 5.

PMID:
22767144
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Molecular mechanism implicated in Pemetrexed-induced apoptosis in human melanoma cells.

Buqué A, Muhialdin JSh, Muñoz A, Calvo B, Carrera S, Aresti U, Sancho A, Rubio I, López-Vivanco G.

Mol Cancer. 2012 Apr 26;11:25. doi: 10.1186/1476-4598-11-25.

PMID:
22537194
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.

Rosell R, Carcereny E, Gervais R, Vergnenegre A, Massuti B, Felip E, Palmero R, Garcia-Gomez R, Pallares C, Sanchez JM, Porta R, Cobo M, Garrido P, Longo F, Moran T, Insa A, De Marinis F, Corre R, Bover I, Illiano A, Dansin E, de Castro J, Milella M, Reguart N, Altavilla G, Jimenez U, Provencio M, Moreno MA, Terrasa J, Muñoz-Langa J, Valdivia J, Isla D, Domine M, Molinier O, Mazieres J, Baize N, Garcia-Campelo R, Robinet G, Rodriguez-Abreu D, Lopez-Vivanco G, Gebbia V, Ferrera-Delgado L, Bombaron P, Bernabe R, Bearz A, Artal A, Cortesi E, Rolfo C, Sanchez-Ronco M, Drozdowskyj A, Queralt C, de Aguirre I, Ramirez JL, Sanchez JJ, Molina MA, Taron M, Paz-Ares L; Spanish Lung Cancer Group in collaboration with Groupe Français de Pneumo-Cancérologie and Associazione Italiana Oncologia Toracica.

Lancet Oncol. 2012 Mar;13(3):239-46. doi: 10.1016/S1470-2045(11)70393-X. Epub 2012 Jan 26.

PMID:
22285168
[PubMed - indexed for MEDLINE]
9.

Identification of a biomarker panel for colorectal cancer diagnosis.

García-Bilbao A, Armañanzas R, Ispizua Z, Calvo B, Alonso-Varona A, Inza I, Larrañaga P, López-Vivanco G, Suárez-Merino B, Betanzos M.

BMC Cancer. 2012 Jan 26;12:43. doi: 10.1186/1471-2407-12-43.

PMID:
22280244
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Fixed-dose-rate gemcitabine infusion in patients with advanced pancreatic or biliary tree adenocarcinoma.

Mané JM, Sancho A, Muñoz A, Rubio I, Fernández R, Carrera S, Fuente N, Ballesteros D, Casas R, Marrodán I, Mielgo X, López-Vivanco G.

Tumori. 2010 May-Jun;96(3):405-10.

PMID:
20845800
[PubMed - indexed for MEDLINE]
11.

Phase I/II and pharmacokinetic study of intravenous vinflunine in combination with cisplatin for the treatment of chemonaive patients with advanced non-small-cell lung cancer.

Souquet PJ, Krzakowski M, Ramlau R, Sun XS, Lopez-Vivanco G, Puozzo C, Pouget JC, Pinel MC, Rosell R.

Clin Lung Cancer. 2010 Mar 1;11(2):105-13. doi: 10.3816/CLC.2010.n.014.

PMID:
20199976
[PubMed - indexed for MEDLINE]
12.

Blood-based CHRNA3 single nucleotide polymorphism and outcome in advanced non-small-cell lung cancer patients.

Carcereny E, Ramirez JL, Sanchez-Ronco M, Isla D, Cobo M, Moran T, de Aguirre I, Okamoto T, Wei J, Provencio M, Lopez-Vivanco G, Camps C, Domine M, Alberola V, Sanchez JM, Massuti B, Mendez P, Taron M, Rosell R.

Lung Cancer. 2010 Jun;68(3):491-7. doi: 10.1016/j.lungcan.2009.08.004. Epub 2009 Sep 5.

PMID:
19733931
[PubMed - indexed for MEDLINE]
13.

Screening for epidermal growth factor receptor mutations in lung cancer.

Rosell R, Moran T, Queralt C, Porta R, Cardenal F, Camps C, Majem M, Lopez-Vivanco G, Isla D, Provencio M, Insa A, Massuti B, Gonzalez-Larriba JL, Paz-Ares L, Bover I, Garcia-Campelo R, Moreno MA, Catot S, Rolfo C, Reguart N, Palmero R, Sánchez JM, Bastus R, Mayo C, Bertran-Alamillo J, Molina MA, Sanchez JJ, Taron M; Spanish Lung Cancer Group.

N Engl J Med. 2009 Sep 3;361(10):958-67. doi: 10.1056/NEJMoa0904554. Epub 2009 Aug 19.

PMID:
19692684
[PubMed - indexed for MEDLINE]
Free Article
14.

Customized treatment in non-small-cell lung cancer based on EGFR mutations and BRCA1 mRNA expression.

Rosell R, Perez-Roca L, Sanchez JJ, Cobo M, Moran T, Chaib I, Provencio M, Domine M, Sala MA, Jimenez U, Diz P, Barneto I, Macias JA, de Las Peñas R, Catot S, Isla D, Sanchez JM, Ibeas R, Lopez-Vivanco G, Oramas J, Mendez P, Reguart N, Blanco R, Taron M.

PLoS One. 2009;4(5):e5133. doi: 10.1371/journal.pone.0005133. Epub 2009 May 5.

PMID:
19415121
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Prognostic factors in cancer of unknown primary site.

Muñoz A, Fuente N, Rubio I, Ferreiro J, Martínez-Bueno A, López-Vivanco G.

Clin Transl Oncol. 2008 Jan;10(1):64-5. No abstract available.

PMID:
18208796
[PubMed - indexed for MEDLINE]
16.

Reversible liver toxicity with adjuvant trastuzumab for localized breast cancer.

Muñoz A, Carrera S, Ferreiro J, de Lobera AR, Mañé JM, López-Vivanco G.

Ann Oncol. 2007 Dec;18(12):2045-6. No abstract available.

PMID:
18083694
[PubMed - indexed for MEDLINE]
Free Article
17.

Sorafenib TARGET trial results in Spanish patients.

Bellmunt J, González-Larriba JL, Climent MA, López-Vivanco G, Urruticoechea L, Albanell J.

Clin Transl Oncol. 2007 Oct;9(10):671-3.

PMID:
17974528
[PubMed - indexed for MEDLINE]
18.

Customizing cisplatin based on quantitative excision repair cross-complementing 1 mRNA expression: a phase III trial in non-small-cell lung cancer.

Cobo M, Isla D, Massuti B, Montes A, Sanchez JM, Provencio M, Viñolas N, Paz-Ares L, Lopez-Vivanco G, Muñoz MA, Felip E, Alberola V, Camps C, Domine M, Sanchez JJ, Sanchez-Ronco M, Danenberg K, Taron M, Gandara D, Rosell R.

J Clin Oncol. 2007 Jul 1;25(19):2747-54.

PMID:
17602080
[PubMed - indexed for MEDLINE]
Free Article
19.

[Prognostic factors associated with resectable pulmonary metastases from colorectal cancer].

Muñoz Llarena A, Carrera Revilla S, Gil-Negrete Laborda A, Pac Ferrer J, Barceló Galíndez R, López Vivanco G.

Arch Bronconeumol. 2007 Jun;43(6):309-16. Review. Spanish.

PMID:
17583640
[PubMed - indexed for MEDLINE]
Free Article
20.

Efficacy and safety of cisplatin and capecitabine in combination as first line treatment for unselected patients with advanced gastric cancer.

Viteri A, Muñoz A, Rubio I, Barceló R, Martínez-Bueno A, Fernández R, Carrera S, López-Vivanco G.

Acta Oncol. 2007;46(3):397-9. No abstract available.

PMID:
17450479
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk